According to the Vegas Information Network, California Governor Gavin Newsom announced on December 30 that the densely populated Southern California had a British variant of the new coronavirus infection. The news was announced during an online conversation between Newsom and Fauci, director of the National Institute of Infectious Diseases and chief adviser on epidemic prevention at the White House.

Recently, Colorado first detected two cases of variant COVID-19. Experts from the Centers for Disease Control and Prevention (CDC) said that the variant COVID-19 virus circulating in the UK may have spread from person to person in the United States.

Officials said that the confirmed infected persons in Colorado and California have never travelled recently and are currently in isolation and treatment.

▲(Huayu data map)

California Governor Newsom said that the variant COVID-19 infection in California was a 30-year-old man in San Diego County, Southern California, who was tested and confirmed two days after the onset of symptoms.

At the time when the mutated new coronavirus in California, the state government is under tremendous pressure from the growing pandemic crisis. The number of infected patients in the hospital is increasing and is expected to continue to increase in the next few weeks. State health officials are very worried about the folk New Year gatherings in the next few days.

On the 30th, Henry Walke, director of the Department of Prevention and Emerging Infections, said that although there is no evidence that the virus will cause more severe symptoms or increase the fatality rate, it may increase more confirmed cases and further impact the already overwhelmed medical system.

Florida health officials said on the 1st that the British new crown variant virus strain has been detected, which is the third state in the United States to report a confirmed case of the virus.

“There is evidence that Martin County, Florida, has the first case of a mutation of the British new crown virus. This man is a male in his 20s and has no history of travel.” The Florida Department of Health said on Twitter on Thursday.

Colorado and California have successively discovered confirmed cases of the British new crown mutation this week.

However, according to media reports, the confirmed cases in Colorado and California have no travel history.

Nevada has not yet found its traces, but will gradually strengthen monitoring. Experts said that although this particular strain of the virus appears to be more contagious, no new testing is currently required.

Shadaba Asad, Medical Director of Infectious Diseases at the University of Las Vegas Medical Center (UMC), said: “Preliminary epidemiological indicators do show that this particular variant is associated with increased transmissibility. As of now, there is no Evidence shows that the newly discovered variant causes more serious diseases than the viruses we have seen before.”

In the medical world, it is often referred to as “B117”. Although this strain of the virus has only recently been discovered in the United States, Assad speculates that it may have existed here longer than people thought.

She said: “This may have happened in the United States, and when it happened, we were not actually looking for it. We don’t know how popular this variant is in the United States, because until recently, we had no strain monitoring in the United States. Put a lot of energy into it.”

Dr. Mark Pandori, head of testing at the Nevada Public Health Laboratory, said that so far, the strain has not been found in Nevada. “This is a question of when, not whether it will happen. Even if it was discovered in Colorado, there is currently no evidence to show whether it has spread to other parts of the United States.”

Pandora said that the Nevada Public Health Laboratory is strengthening genetic monitoring and testing capabilities. He said: “After the holidays, we will be able to screen every positive case in Nevada, looking for the genome associated with B117, in order to determine as widely as possible whether this strain is in our community. As we enter 2021 , The test bandwidth of the Nevada Public Health Laboratory should be much larger than at the end of 2020.”

Assad said: “The usual PCR tests available should still be able to detect this mutation. Routine PCR tests depend on detecting multiple genes to identify the COVID-19 virus. If you have been diagnosed with the new coronavirus and have a certain degree of natural immunity Or being vaccinated, the immunity conferred by these two processes should still be effective against this specific variant.”

Pandora said: “In order to escape the immunity generated by vaccines or natural infections, the COVID virus must accumulate multiple mutations in the spike protein. The spread of this particular virus strain is a concern for health experts because the healthcare system is very Bo. I beg people to wear masks and social distancing to help slow the spread of the virus. The same measures taken to prevent wider spread also apply to new strains. As for whether it will cause more cases? Only time Can answer, and there are many variables. If we continue to implement all these mitigation measures, we hope that the spread of this variant can still be controlled. If the virus spreads more easily, it means that these measures are more important than in the past.”

Fauci, director of the National Institute of Infectious Diseases and chief adviser to the White House for epidemic prevention, said that he is not surprised that the United States has recently been infected with the British variant of the new coronavirus, but he said that there is currently no sign that the virus is more than the new coronavirus that has appeared in the United States since February. It is pathogenic, and there is no evidence that the virus will weaken the protection of the new crown vaccine. Fauci called on the people to remain calm and not to panic.

Fauci predicts that April next year is expected to become an “open season” for vaccines, allowing people to get vaccinated if they want. If Americans can actively vaccinate the new crown vaccine from April to July, it is expected that 70% to 85% of the people will be vaccinated in early autumn. Formation of herd immunity, it is expected to gradually return to a normal life.

As of 3 o’clock on December 31, there were more than 19.74 million confirmed cases of new coronavirus infection in the United States and more than 342,000 deaths. (Original title: Variant new coronavirus has spread to Americans, but not found in Nevada)

During the two days of December 27 and 28, the COVID-19 virus was found continuously in many countries, and the mutated virus earlier appeared in Italy than in the UK. In this regard, China has launched actions, the National Health Commission has decided to set up an expert committee, and Wuhan has already started the emergency vaccination work!

Body:

At present, COVID-19 epidemic is still spreading globally. On December 27 and 28, there was bad news in 20 countries all night. A novel coronavirus appeared in Italy before it appeared in Britain and a novel Coronavirus in South Korea!
In this regard, China has taken concrete actions!

According to the CCTV News on December 29, The Italian media reported on December 28 that The novel Coronavirus variant was isolated from the sample of an asymptomatic infected person in August this year, and the 501 position of virus S thorn protein was mutated.
It is similar to the virus variant found in the UK, but is thought to predate the latter.

On the same day, South Korea’s Central Epidemic Prevention Department said that novel Coronavirus was detected in samples taken from three British immigrants.
The infected people, a family of three living in the British capital London, have tested positive for the coronavirus after arriving in South Korea on June 22 and are now under quarantine.
In addition, four people from a family who returned to Korea from the United Kingdom on 8 November and 13 December were confirmed to be infected with COVID-19, including a man in his 80s who was confirmed after his death.
Korea is sequencing the genome of their sample to confirm whether the novel coronavirus is infected.

The Jordanian Minister of Health Nazir Obeidat said on The 27th that a Jordanian couple who had returned from the UK on the 19th had diagnosed a novel coronavirus and were in isolation and in “very good health” under the supervision of medical experts.

Novel Coronavirus infection was diagnosed in two travelers arriving from The UK earlier this month, the Norwegian Public Health Institute said Wednesday. The institute has notified the governments of two Norwegian cities to follow up on contacts and additional tests.

It is worth noting that nearly time for the multinational all variation will be found coronavirus, on December 26, Canada two variants will be coronavirus infection was found, vancouver, said Brian conway, director of the infectious disease center medical “, obviously, I am not surprised, before that was found two confirmed cases, variation will be coronavirus has been spread in Canada.”
“We need to do more virus testing to find out where the couple infected with the mutation Coronavirus, and only by understanding the ‘chain of transmission’ can we break it off.”
Conway said.

Faced with novel Coronavirus that has swept the world, vaccine companies around the world are working hard to develop a safe and effective vaccine, while the mRNA novel coronavirus vaccine produced by Pfizer inc. caused a frenzy of buying in countries around the world immediately after it was announced as a successful clinical trial in November.
In early December Pfizer’s vaccine was given emergency approval for sale in the United States and other Western countries, and Israel, whose relations with the United States have always been pro-American, is in the vanguard.

Since the Israeli Health Ministry began a mass vaccination campaign against Pfizer on December 20, half a million people across Israel have been vaccinated against the vaccine.
Previously, however, in countries such as Britain and the United States after vaccination, some of the new champions league vaccine tester in vaccinations appeared a severe allergic reaction, after testing and before Israel, ready to start large-scale Pfizer vaccine, there are a lot of people are not willing to Israel for vaccination, they worry that vaccination is likely to endanger the safety of his own life, and it turns out that their worry is not without reason.

Israeli media reported that an 88-year-old man died in a Jerusalem hospital on the afternoon of December 29 after receiving a COVID-19 vaccine.
Against the backdrop of mass vaccination in Israel, the elderly and young children were among the first protected groups to be vaccinated, but the elderly man collapsed after returning home in the afternoon.
Paramedics rushed the man to Sasanskopps Medical Center, but nothing could be done.

News that the elderly man died after receiving Pfizer’s vaccine has raised concerns in Israel and around the world about the safety of Pfizer’s vaccine.
Given that this is the second death from COVID-19 in Israel (the first was on December 24th), is Pfizer’s vaccine as safe as the United States and other countries claim?
Are they better than the inactivated vaccines approved for sale in China on December 31?

Pfizer’s problem: Due to government prodding, allergic reactions have been deliberately diluted or glossed over

While in the third phase of clinical trial, Pfizer has not found the vaccine will produce large adverse reactions, but Pfizer vaccine phase iii trial was conducted under the financial support of the government, although also has carried on the careful observation, but the U.S. financial sector hopes to Pfizer vaccine on the market for production as soon as possible.

According to the US Food and Drug Administration (FDA), “The Pfizer vaccine, like any other vaccine, has undergone rigorous testing and is no different from any other vaccine.
Although there is a high risk of an allergic reaction within an hour of the injection, the reaction is not fatal.”
But the FDA played down or glossed over the potential for serious adverse reactions in the U.K. and Israel in order to win a sale, according to a person familiar with the company, leading to some unusual cases after Pfizer’s vaccines had been marketed in the U.S. and U.K.

Last week, British health authorities reported two cases of severe allergy to Pfizer’s vaccine, after two health workers in Alaska suffered severe reactions to the novel coronavirus vaccine.
The UK health service said it would continue to monitor the sensitivity of the general population to the vaccine and would not recommend the COVID-19 vaccine to people with a history of allergies.
Still, the FDA said, “The benefits of the Pfizer vaccine far outweigh any risks it theoretically would pose.”

And about the effectiveness of Pfizer vaccine, after the first vaccination needle, the vaccine to prevent will be coronavirus infection success rate can reach 52%, while the second needle after inoculation, it will be coronavirus immune can reach 90%, but is still part of the vaccinated after accepting vaccine appeared uncomfortable reactions such as headache, fever, but the expert thinks, the scope of these basic are able to control.

What are the differences between the Pfizer vaccine and the Chinese vaccine?
Which vaccine is safer?

In the field of novel Coronavirus research and development, China’s vaccine research and development progress has always been in the first echelon.
On December 31, The State Council of China officially approved sinopac’s inactivated COVID-19 vaccine to be marketed with additional conditions. In the phase III clinical trial, the protection ability of the vaccine against the general population was around 79.34%.
So you might wonder: Why are Chinese vaccines less effective than American-made Pfizer vaccines?
What is the difference between them?

In fact you don’t have to worry about, two kinds of vaccines for the protection of ordinary people, do not have too big difference, but the preparation of two vaccines way has some differences: Pfizer, the world leading technology is relatively advanced production enterprises, the production of the new vaccine is used by mRNA technology, the vaccine production technology is advanced, vaccinated after vaccination does not face the risk of infection, also won’t cause will be coronavirus mutation;
Moreover, the in vitro gene transcription technology on which the mRNA vaccine relies is also very mature. Compared with the production of traditional vaccine, which takes 5-6 months, the mRNA vaccine can be completed within 40 days, so as to deal with the threat of novel Coronavirus to the greatest extent.

So traditional inactivated vaccines have no advantage?
In fact, it’s not.
The new vaccine can only be stored in a special freezer at minus 70 degrees Celsius for a long time. It has a shelf life of only 15 days once it is transported in a regular temperature-controlled truck.
The vaccine is only valid for five days at terminals between two and eight degrees Celsius, making it a serious test of refrigerated transport technology around the world.

As a traditional vaccine, inactivated virus vaccine has the characteristics of mature preparation technology and good public acceptance, and there is no special requirement for the storage environment of the vaccine. It can only be stored in a general refrigerated storage environment, which is convenient for long-distance transportation and preservation.
So far, most of the vaccine manufacturers in China have chosen the inactivated vaccine technology, because the adverse reactions produced by the inactivated vaccine can be predicted and prevented, while the severe adverse reactions produced by the vaccine produced by the mRNA technology are often unpredictable, and may even lead to the death of patients with poor immunity.

In addition, the inactivated vaccines also contain broad-spectrum viral proteins, and antibodies produced by other viral proteins in the inactivated vaccines can continue to function even after the virus mutates, compared with mRNA vaccines that only transcribe some of the virus’s genes.
And as to the problem of vaccine efficacy, we don’t have to worry about, because China has a large number of drug companies are stepping up production or introduce will be coronavirus vaccine, and the third phase of clinical data shows the vaccine effectiveness is only a conservative estimate, believe that with time, China will be able to produce higher vaccine or improve the efficient, resistance to disease in the world history glorious chapter of their own.

Mr Trump, with his “America first” policies, is seen in part as the voice of conservative white Americans.
Under the Trump administration, the issue of racial conflict in the United States has become prominent, and the recent wave of anti-racial discrimination demonstrations has swept across the United States.
However, according to us media reports, on one issue, the US government plans to implement “black First”, which is to give priority to the coVID-19 vaccine to African Americans.

“Who should get the vaccine first?
Racial considerations in the United States’ epidemic [response] plan.”
9, the New York times reported the topic, along with the advancement of vaccine research and development, the U.S. federal health officials have begun negotiating decide who will be the first batch of vaccination will be coronavirus vaccine, and some officials and experts are considering a controversial choice: the infection will be coronavirus ratio higher African-American and Hispanic, row in front of the other groups.

The New York Times reported that the vaccine is expected to be available this winter, but that it could take months before it is widely available to all Americans.

In April, the CENTERS for Disease Control and Prevention and an advisory committee of outside health experts, known as the Advisory Committee on Immunization, reportedly began working on a ranking system that could be rolled out in the United States.
Under the initial plan, any vaccine approved for use would be provided first to key health and national security officials, then to workers in other key areas and high-risk groups — the elderly rather than children, and those with underlying diseases rather than those who are relatively healthy.
Moreover, some officials and expert advisers are considering a controversial choice: novel Coronavirus has a higher rate of infection among blacks and Latinos than any other race.

To speed up distribution, the most promising vaccines will begin production before they pass the final stages of clinical trials and are approved for use by the Food and Drug Administration, the report said.
But there will be a gap between the first vaccines coming off the production line and the stockpile needed to vaccinate all Americans.
“I would say [the gap] will last for months.”
Jose R. Romero, the chairman of the immunization advisory Committee, predicted.

File photo from The New York Times

Because of the gap, there is a question of who will be the first to get vaccinated.
The committee has been discussing the issue with the CDC for some time.
According to the New York Times, race and ethnicity are the most debated priorities in vaccination.

Dr. Sharon Frey, a professor of epidemiology at St. Louis University, presented the health gap between the African American and Hispanic populations at a recent conference.
She believes it is important that these groups are at the top of vaccination priorities.
“Perhaps not for the whole population, but certainly for those living in crowded urban areas.”

The New York Times noted that African and Hispanic populations were three times as likely to be infected with novel Coronavirus and nearly twice as likely to die.
Many of them cannot work from home because of the nature of their jobs, rely on public transport or live in small rooms, which increases their risk of exposure to the virus.

But the report also notes that the issue has prompted calls for “racial justice” in several private meetings and, most recently, in a public one.
Some medical experts are not convinced that the choice is based on science and expect the court to challenge it, fearing that giving priority to minorities would undermine public trust in the vaccine.

In the end, this rare “black first” is not a reflection of the rising status of African-americans, but of their inferior status in American society.